Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content. This indicates a permission issue rather than an update to the study information.SummaryDifference19%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This reflects a routine version update and does not alter the study details or other visible content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays a standard error screen indicating the content is temporarily unavailable. The previously visible study record details are no longer shown.SummaryDifference17%

- Check78 days agoChange DetectedThe study page now indicates the trial is no longer recruiting participants. The update notes that the last known status was set by Academic and Community Cancer Research United on 2024-07 and that the last verification status is Unknown.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.